Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Lycke

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Arthritis and Rheumatism|May 30, 2009
Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritisAnnemarie Hasselberg, Karin Schön, Andrej Tarkowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formationYu Fang, Lisa Larsson, Johan Mattsson, et al.
Mucosal Immunology|May 16, 2023
Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cellsCharlotta Hansson, Cristina Lebrero-Fernández, Karin Schön, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infectionAli A Akhiani, Karin Schön, Lennart E Franzén, et al.
Neuroreport|September 28, 2002
Facial nerve lesion response; strain differences but no involvement of IFN-gamma, STAT4 or STAT6Olle Lidman, Matt Fraidakis, Nils Lycke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvantEva Gärdby, Jens Wrammert, Karin Schön, et al.
Journal of Reproductive Immunology|June 9, 2009
CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosaKelly A Cunningham, Alison J Carey, Nils Lycke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2015
Cutting Edge: Retinoic Acid Signaling in B Cells Is Essential for Oral Immunization and Microflora CompositionEirini Pantazi, Ellen Marks, Emilie Stolarczyk, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 17, 2025
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple SclerosisSofia Sandgren, Lenka Novakova, Markus Axelsson, et al.
Science Immunology|July 1, 2022
Peyer's patch T<sub>H</sub>17 cells are dispensable for gut IgA responses to oral immunizationInta Gribonika, Anneli Strömberg, Cristina Lebrero-Fernandez, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|May 30, 2009
Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritisAnnemarie Hasselberg, Karin Schön, Andrej Tarkowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formationYu Fang, Lisa Larsson, Johan Mattsson, et al.
Mucosal Immunology|May 16, 2023
Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cellsCharlotta Hansson, Cristina Lebrero-Fernández, Karin Schön, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infectionAli A Akhiani, Karin Schön, Lennart E Franzén, et al.
Neuroreport|September 28, 2002
Facial nerve lesion response; strain differences but no involvement of IFN-gamma, STAT4 or STAT6Olle Lidman, Matt Fraidakis, Nils Lycke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvantEva Gärdby, Jens Wrammert, Karin Schön, et al.
Journal of Reproductive Immunology|June 9, 2009
CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosaKelly A Cunningham, Alison J Carey, Nils Lycke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2015
Cutting Edge: Retinoic Acid Signaling in B Cells Is Essential for Oral Immunization and Microflora CompositionEirini Pantazi, Ellen Marks, Emilie Stolarczyk, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 17, 2025
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple SclerosisSofia Sandgren, Lenka Novakova, Markus Axelsson, et al.
Science Immunology|July 1, 2022
Peyer's patch T<sub>H</sub>17 cells are dispensable for gut IgA responses to oral immunizationInta Gribonika, Anneli Strömberg, Cristina Lebrero-Fernandez, et al.
Pageof 5